WO2010053329A3 - Nouveau lipide cationique dérivé d'oligopeptides, procédé de préparation de celui-ci et système d'administration comprenant celui-ci - Google Patents

Nouveau lipide cationique dérivé d'oligopeptides, procédé de préparation de celui-ci et système d'administration comprenant celui-ci Download PDF

Info

Publication number
WO2010053329A3
WO2010053329A3 PCT/KR2009/006567 KR2009006567W WO2010053329A3 WO 2010053329 A3 WO2010053329 A3 WO 2010053329A3 KR 2009006567 W KR2009006567 W KR 2009006567W WO 2010053329 A3 WO2010053329 A3 WO 2010053329A3
Authority
WO
WIPO (PCT)
Prior art keywords
delivery system
nucleic acid
same
cationic lipid
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2009/006567
Other languages
English (en)
Korean (ko)
Other versions
WO2010053329A2 (fr
Inventor
오유경
이한영
한수은
심가용
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Korea University Research and Business Foundation
SNU R&DB Foundation
Original Assignee
Korea University Research and Business Foundation
SNU R&DB Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea University Research and Business Foundation, SNU R&DB Foundation filed Critical Korea University Research and Business Foundation
Publication of WO2010053329A2 publication Critical patent/WO2010053329A2/fr
Publication of WO2010053329A3 publication Critical patent/WO2010053329A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/12—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B1/00—Nanostructures formed by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne un nouveau lipide cationique dérivé d'oligopeptides, un procédé de préparation de celui-ci et un système d'administration d'acide nucléique comprenant celui-ci. Le lipide cationique de l'invention est utilisé pour préparer le système d'administration d'acide nucléique. Le lipide cationique de l'invention peut être préparé et purifié à l'aide d'un procédé simple qui présente des avantages économiques accrus en vue d'une production de masse. De plus, le système d'administration d'acide nucléique comprenant le lipide cationique de l'invention permet non seulement d'accroître considérablement l'efficacité de médicaments oligonucléotidiques vecteurs tels que l'acide ribonucléique, le petit ARN interférent, un oligonucléotide antisens, un aptamère d'acide nucléique et analogue dans des cellules, mais aussi de réduire la cytotoxicité. Le système d'administration d'acide nucléique de l'invention permet par conséquent d'améliorer les effets thérapeutiques de traitements à base d'acide nucléique.
PCT/KR2009/006567 2008-11-10 2009-11-10 Nouveau lipide cationique dérivé d'oligopeptides, procédé de préparation de celui-ci et système d'administration comprenant celui-ci Ceased WO2010053329A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020080111275A KR100909786B1 (ko) 2008-11-10 2008-11-10 올리고 펩티드를 수식한 신규한 양이온성 지질, 그의 제조 방법 및 그를 포함하는 전달체
KR10-2008-0111275 2008-11-10

Publications (2)

Publication Number Publication Date
WO2010053329A2 WO2010053329A2 (fr) 2010-05-14
WO2010053329A3 true WO2010053329A3 (fr) 2010-08-19

Family

ID=41338037

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2009/006567 Ceased WO2010053329A2 (fr) 2008-11-10 2009-11-10 Nouveau lipide cationique dérivé d'oligopeptides, procédé de préparation de celui-ci et système d'administration comprenant celui-ci

Country Status (2)

Country Link
KR (1) KR100909786B1 (fr)
WO (1) WO2010053329A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011116152A2 (fr) * 2010-03-16 2011-09-22 Sanford -Burnham Medical Research Institute Administration d'agents par le biais de l'utilisation de nanoparticules interférentes
CN103760428B (zh) * 2014-01-24 2016-01-27 上海同耀通信技术有限公司 人体组织液的模拟液
PL3458074T3 (pl) * 2016-05-16 2024-11-12 Board Of Regents Of The University Of Texas System KOMPOZYCJA DO DOSTARCZANIA tRNA W POSTACI NANOCZĄSTEK I SPOSOBY ICH STOSOWANIA
US12357580B2 (en) 2018-06-19 2025-07-15 The Board Of Regents Of The University Of Texas System Lipid nanoparticle compositions for delivery of mRNA and long nucleic acids
US12509552B2 (en) * 2021-04-08 2025-12-30 The Curators Of The University Of Missouri Lipidated poly(amino acid) nanostructures

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4600526A (en) * 1982-09-22 1986-07-15 Centre National de la Recherche Schientifique (C N R S) Lipopeptides, their preparation and their application as emulsifiers
KR100807060B1 (ko) * 2007-08-28 2008-02-25 고려대학교 산학협력단 신규한 양이온성 지질, 그의 제조 방법 및 그를 포함하는전달체

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4600526A (en) * 1982-09-22 1986-07-15 Centre National de la Recherche Schientifique (C N R S) Lipopeptides, their preparation and their application as emulsifiers
KR100807060B1 (ko) * 2007-08-28 2008-02-25 고려대학교 산학협력단 신규한 양이온성 지질, 그의 제조 방법 및 그를 포함하는전달체

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
"ACS Symposium Series, 1989, 384 (Polym. Assoc. Struct.)", 1989, ISSN: 0097-6156, article GALLOT, B. ET AL.: "Liquid crystalline phases and emulsifying properties of block copolymer hydrophobic aliphatic and hydrophilic peptidic chains", pages: 116 - 128 *

Also Published As

Publication number Publication date
WO2010053329A2 (fr) 2010-05-14
KR100909786B1 (ko) 2009-07-29

Similar Documents

Publication Publication Date Title
Perron et al. Protein interactions and complexes in human microRNA biogenesis and function
MX2014000053A (es) Liposomas con relacion nitrogeno:fosfato (n:p) util para el suministro de moleculas de arn.
WO2008118212A3 (fr) Administration in vivo d'arn double brin à une cellule cible
MX2010009465A (es) Una celula fermentadora de azucar pentosa.
WO2010014895A3 (fr) Compositions de nanoparticules pour un système d'administration d'acides nucléiques
WO2009028824A3 (fr) Nouveau lipide cationique, procédé de préparation de ce dernier et système d'administration le comprenant
NZ593618A (en) Gnaq targeted dsrna compositions and methods for inhibiting expression
NZ592867A (en) Compositions and methods for inhibiting expression of transthyretin
WO2010053329A3 (fr) Nouveau lipide cationique dérivé d'oligopeptides, procédé de préparation de celui-ci et système d'administration comprenant celui-ci
MX2020011807A (es) Composiciones y metodos para inhibir la expresion genica del virus de hepatitis b.
HK1200089A1 (en) Biodegradable lipids for the delivery of active agents
WO2009086428A3 (fr) Procédés et compositions destinés à augmenter l'expression génique
WO2012170957A3 (fr) Liposomes-rétinoïdes permettant d'améliorer la modulation de l'expression de hsp47
WO2013173757A8 (fr) Procédé pour traiter le cancer du poumon non à petites cellules
WO2010056043A3 (fr) Anticorps à pénétration cellulaire, spécifique de séquence et hydrolysant les acides nucléiques, son procédé de préparation et composition pharmaceutique le contenant
NZ612285A (en) Enhanced immune response in bovine species
PH12013502600A1 (en) Rabies virus like particle production in plants
NZ700897A (en) Lowering saturated fatty acid content of plant seeds
WO2012156817A3 (fr) Méthode de traitement du cancer bronchopulmonaire non à petites cellules
WO2007137156A8 (fr) Modulation d'aha par l'arn et utilisateurs thérapeutiques de celle-ci
WO2013058482A3 (fr) Médicament anticancéreux à base d'acide nucléique multifonctionnel apte à cibler et de traiter, procédé de préparation de celui-ci et composition anticancéreuse le comprenant
MY185050A (en) A pentose sugar fermenting cell
MX2011008542A (es) Molecula de acido nucleico de un racimo biosintetico que codifica sintasas peptidicas no ribosomales y usos de la misma.
WO2011054939A3 (fr) Compositions et procédés pour inhiber l'expression de gènes kif10
WO2011132854A3 (fr) E. coli hétérogène pour l'amélioration de la teneur en acide gras au moyen de la biosynthèse d'acide gras et son procédé de préparation

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09825012

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09825012

Country of ref document: EP

Kind code of ref document: A2